News
Ocugen says it will pursue submission of a biologics license application for its ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'Ocugen says it will pursue submission of a biologics license application for its COVID-19 vaccine candidate, COVAXIN in US "The Company will no longer pursue an Emergency Use Authorization for COVAXIN ," it says in a statement.'
Ocugen says it will pursue submission of a biologics license application (BLA) for its COVID-19 vaccine candidate, COVAXIN in US
"The Company will no longer pursue an Emergency Use Authorization for COVAXIN (developed by Bharat Biotech & ICMR)," it says in a statement.— ANI (@ANI) June 11, 2021
(The above story first appeared on LatestLY on Jun 11, 2021 12:10 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
